ムコリピドーシスIV型、ムコ脂質症IV型
- 関
- cherry red spot myoclonus syndrome、I-cell disease、mucolipidosis、mucolipidosis I、mucolipidosis II、mucolipidosis III、mucolipidosis IV、mucolipidosis type I、mucolipidosis type II、mucolipidosis type III、pseudo-Hurler polydystrophy、sialidosis
WordNet
- write by means of a keyboard with types; "type the acceptance letter, please" (同)typewrite
- a small metal block bearing a raised character on one end; produces a printed character when inked and pressed on paper; "he dropped a case of type, so they made him pick them up"
- (biology) the taxonomic group whose characteristics are used to define the next higher taxon
- a subdivision of a particular kind of thing; "what type of sculpture do you prefer?"
- all of the tokens of the same symbol; "the word `element contains five different types of character"
- printed characters; "small type is hard to read"
- identify as belonging to a certain type; "Such people can practically be typed" (同)typecast
- the 9th letter of the Roman alphabet (同)i
- writing done with a typewriter (同)typewriting
PrepTutorEJDIC
- 〈C〉(…の)『型』,タイプ,類型,種類(kind)《+of+名》 / 〈C〉(その種類の特質を最もよく表している)『典型』,手本,模範《+of+名》 / 〈U〉《集合的に》活字;〈C〉(1個の)活字 / 〈U〉(印刷された)字体,活字 / 〈C〉(貨幣・メダルなどの)模様,図柄 / 〈C〉血液型(blood group) / …‘を'タイプに打つ / (…として)…‘を'分類する《+名+as+名(doing)》 / …‘の'型を決める / タイプライターを打つ
- 『私は』私が
- iodineの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/25 15:49:25」(JST)
[Wiki en表示]
←
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2008) |
Mucolipidosis type IV |
Classification and external resources |
ICD-10 |
E75.1 |
OMIM |
252650 |
DiseasesDB |
32693 |
MeSH |
D009081 |
GeneReviews |
|
Mucolipidosis type IV (ML IV or ML4) is an autosomal recessive lysosomal storage disorder. Individuals with the disorder have many symptoms including delayed psychomotor development and various ocular aberrations. The disorder is caused by mutations in the MCOLN1 gene, which encodes a non-selective cation channel, mucolipin1.[1][2] These mutations disrupt cellular functions and lead to a neurodevelopmental disorder through an unknown mechanism. Researchers dispute the physiological role of the protein product and which ion it transports.[3]
Contents
- 1 Symptoms and Signs
- 2 Pathophysiology
- 3 Treatment/Management
- 4 Epidemiology
- 5 References
- 6 External links
Symptoms and Signs
Most patients with ML IV show psychomotor retardation (i.e., delayed development of movement and coordination), corneal opacity, retinal degeneration and other ophthalmological abnormalities. Other symptoms include agenesis of the corpus callosum, iron deficiency resulting from an absence of acid secretion in the stomach, achlorhydria. Achlorhydria in these patients results in an increase in blood gastrin levels. These symptoms typically manifest early in life (within the first year). After disease onset there occurs a period of stability, typically lasting two to three decades during which very little disease progression occurs.[4]
Pathophysiology
Mucolipidosis type IV has an autosomal recessive pattern of inheritance.
Mucolipin1 is thought to be localized in endosomes. An important property of mucolipin1 is that decreasing pH (acidification) results in deactivation of the protein, likely through an assembly defect. There are at least 29 known mutations in MCOLN1, located throughout the gene.[5] Many of the known mutations result in no expression of mucolipin1. Milder mutations, such as ΔF408 and V446L, produce a dysfunctioning form of the cation channel.[6] Mutations that alter only the C-terminal of the protein also result in a mild phenotype of the disorder, usually sparing the brain.[7] ML IV causes affected cells to accumulate auto-fluorescent vacuoles considered to be aberrant lysosomes.[8] Several evidences exist for a defect in both exocytosis and endocytosis.[9] There are conflicting indications of abnormal lysosomal pH in MLIV.[citation needed] It is not yet clear why these abnormalities will cause incomplete development of the brain, achlorhydria, and failure in the maintenance of retinal tissue.
Treatment/Management
There is no specific treatment to this disorder. However, several symptoms may be alleviated. For instance, anemia is treated by iron supplements. Some of the movement deficiencies may be corrected with orthopedic intervention. The corneal clouding can be, at least, temporarily corrected by corneal transplantation. See the equivalent section in the main mucolipidosis article.
Epidemiology
Mucolipidosis type IV is severely under-diagnosed. It is often misdiagnosed as cerebral palsy. In the Ashkenazi Jewish population there are two severe mutations with a higher carrier frequency[10] of 1:90 to 1:100.[11]
References
- ^ Nilius, B.; Owsianik, G.; Voets, T.; Peters, J. A. (2007). "Transient Receptor Potential Cation Channels in Disease". Physiological Reviews 87 (1): 165–217. doi:10.1152/physrev.00021.2006. PMID 17237345.
- ^ Sun, M.; Goldin, E; Stahl, S; Falardeau, J. L.; Kennedy, J. C.; Acierno Jr, J. S.; Bove, C; Kaneski, C. R.; Nagle, J; Bromley, M. C.; Colman, M; Schiffmann, R; Slaugenhaupt, S. A. (2000). "Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel". Human Molecular Genetics 9 (17): 2471–8. doi:10.1093/hmg/9.17.2471. PMID 11030752.
- ^ Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Delling, Markus; Wang, Fudi; Kurz, Tino; Xu, Haoxing (2008). "The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel". Nature 455 (7215): 992. Bibcode:2008Natur.455..992D. doi:10.1038/nature07311. PMID 18794901.
- ^ Wakabayashi, K.; Gustafson, A. M.; Sidransky, E.; Goldin, E. (2011). "Mucolipidosis type IV: An update". Molecular Genetics and Metabolism 104 (3): 206–213. PMID 21763169.
- ^ Goldin E, Slaugenhaupt SA, Smith J, Schiffmann R (2005) Mucolipidosis IV, GeneReviews at GeneTests: Medical Genetics Information Resource http://www.ncbi.nlm.nih.gov/books/NBK1214/
- ^ Altarescu, G.; Sun, M.; Moore, D. F.; Smith, J. A.; Wiggs, E. A.; Solomon, B. I.; Patronas, N. J.; Frei, K. P.; Gupta, S.; Kaneski, C. R.; Quarrell, O. W.; Slaugenhaupt, S. A.; Goldin, E.; Schiffmann, R. (2002). "The neurogenetics of mucolipidosis type IV". Neurology 59 (3): 306. doi:10.1212/wnl.59.3.306. PMID 12182165.
- ^ Goldin, E.; Caruso, R. C.; Benko, W.; Kaneski, C. R.; Stahl, S.; Schiffmann, R. (2008). "Isolated Ocular Disease is Associated with Decreased Mucolipin-1 Channel Conductance". Investigative Ophthalmology & Visual Science 49 (7): 3134. doi:10.1167/iovs.07-1649. PMID 18326692.
- ^ Goldin, Ehud; Blanchette-Mackie, E Joan; Dwyer, Nancy K; Pentchev, Peter G; Brady, Roscoe O (1995). "Cultured Skin Fibroblasts Derived from Patients with Mucolipidosis 4 Are Auto-Fluorescent". Pediatric Research 37 (6): 687. doi:10.1203/00006450-199506000-00003. PMID 7651750.
- ^ Chen, C. S.; Bach, G; Pagano, R. E. (1998). "Abnormal transport along the lysosomal pathway in Mucolipidosis, type IV disease". Proceedings of the National Academy of Sciences of the United States of America 95 (11): 6373–6378. Bibcode:1998PNAS...95.6373C. doi:10.1073/pnas.95.11.6373. PMC 27719. PMID 9600972.
- ^ Bach, Gideon; Webb, Michael B.T.; Bargal, Ruth; Zeigler, Marcia; Ekstein, Joseph (2005). "The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations". Human Mutation 26 (6): 591. doi:10.1002/humu.9385. PMID 16287144.
- ^ Bargal, Ruth; Avidan, Nili; Olender, Tzvia; Ben Asher, Edna; Zeigler, Marcia; Raas-Rothschild, Annick; Frumkin, Ayala; Ben-Yoseph, Omer; Friedlender, Yechiel; Lancet, Doron; Bach, Gideon (2001). "Mucolipidosis type IV: NovelMCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population". Human Mutation 17 (5): 397. doi:10.1002/humu.1115. PMID 11317355.
External links
- Mucolipidosis type 4 at NIH's Office of Rare Diseases
- Mucolipidosis IV Foundation
- Gene Test Diagnostic Organization
(LSD) Inborn error of carbohydrate metabolism: glycoproteinosis (E77, 271.8)
|
|
Anabolism |
- Dolichol kinase deficiency
- Congenital disorder of glycosylation
|
|
Post-translational modification
of lysosomal enzymes |
- Mucolipidosis: I-cell disease/II
- Pseudo-Hurler polydystrophy/III
|
|
Catabolism |
- Aspartylglucosaminuria
- Fucosidosis
- mannosidosis
- Alpha-mannosidosis
- Beta-mannosidosis
- Sialidosis
- Schindler disease
|
|
Other |
- solute carrier family (Salla disease)
- Galactosialidosis
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- phospholipid
- cholesterol and steroid
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
|
|
(LSD) Inborn error of lipid metabolism: lipid storage disorders (E75, 272.7–272.8)
|
|
Sphingolipidoses
(to ceramide) |
From ganglioside
(gangliosidoses) |
- Ganglioside: GM1 gangliosidoses
- GM2 gangliosidoses (Sandhoff disease
- Tay–Sachs disease
- AB variant)
|
|
From globoside |
- Globotriaosylceramide: Fabry's disease
|
|
From sphingomyelin |
- Sphingomyelin: phospholipid: Niemann–Pick disease (SMPD1-associated
- type C)
- Glucocerebroside: Gaucher's disease
|
|
From sulfatide
(sulfatidoses
|
- Sulfatide: Metachromatic leukodystrophy
- Multiple sulfatase deficiency
- Galactocerebroside: Krabbe disease
|
|
To sphingosine |
|
|
|
NCL |
- Infantile
- Jansky–Bielschowsky disease
- Batten disease
|
|
Other |
- Cerebrotendineous xanthomatosis
- Cholesteryl ester storage disease (Lysosomal acid lipase deficiency/Wolman disease)
- Sea-blue histiocytosis
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- phospholipid
- cholesterol and steroid
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.
- Mirabelli-Badenier M1, Severino M, Tappino B, Tortora D, Camia F, Zanaboni C, Brera F, Priolo E, Rossi A, Biancheri R, Di Rocco M, Filocamo M.
- Metabolic brain disease.Metab Brain Dis.2014 Aug 26. [Epub ahead of print]
- Mucolipidosis type IV (MLIV) is a very rare disorder of late endosome/lysosome transport, characterized by neurodevelopmental abnormalities and progressive visual impairment owing to corneal clouding and retinal dystrophy. Greater than 70 % of MLIV patients are of Ashkenazi Jewish ancestry. Here we
- PMID 25156245
- A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV.
- Chen CC1, Keller M2, Hess M3, Schiffmann R4, Urban N5, Wolfgardt A6, Schaefer M5, Bracher F6, Biel M7, Wahl-Schott C7, Grimm C1.
- Nature communications.Nat Commun.2014 Aug 14;5:4681. doi: 10.1038/ncomms5681.
- Mucolipidosis type IV (MLIV) is an autosomal recessive lysosomal storage disorder often characterized by severe neurodevelopmental abnormalities and neuro-retinal degeneration. Mutations in the TRPML1 gene are causative for MLIV. We used lead optimization strategies to identify-and MLIV patient fibr
- PMID 25119295
- Cellular Zinc Levels Are Modulated by TRPML1-TMEM163 Interaction.
- Cuajungco MP1, Basilio LC, Silva J, Hart T, Tringali J, Chen CC, Biel M, Grimm C.
- Traffic (Copenhagen, Denmark).Traffic.2014 Aug 6. doi: 10.1111/tra.12205. [Epub ahead of print]
- Mucolipidosis type IV (MLIV) is caused by loss of function mutations in the TRPML1 ion channel. We previously reported that tissue zinc levels in MLIV were abnormally elevated; however, the mechanism behind this pathologic accumulation remains unknown. Here, we identify transmembrane (TMEM)-163 prot
- PMID 25130899
- Microvilli as markers of disordered apical-membrane trafficking and assembly: bowel and liver.
- Thompson RJ1, Knisely AS.
- Hepatology (Baltimore, Md.).Hepatology.2014 Jul;60(1):34-6. doi: 10.1002/hep.27148. Epub 2014 May 12.
- PMID 24668851
Japanese Journal
- Mucolipidosis type IV in a Turkish boy associated with a novel MCOLN1 mutation
- TUYSUZ Beyhan,GOLDIN Ehud,METIN Baris,KORKMAZ Baris,YALCINKAYA Cengiz
- Brain & development 31(9), 702-705, 2009-10-01
- NAID 10026412825
- Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel
Related Links
- Mucolipidosis type IV is an inherited disorder characterized by delayed development and vision impairment that worsens over time. The severe form of the disorder is called typical mucolipidosis type IV, and the mild form ...
- Mucolipidosis type IV (MLIV) is a lysosomal storage disorder characterized by severe neurological and ophthalmologic abnormalities due to defective transport of membrane components in the late endosomal-lysosomal pathway. 5-7 ...
- Mucolipidosis type IV (MLIV) is a neurodevelopmental as well as neurodegenerative disorder with severe psychomotor developmental delay, progressive visual impairment, and achlorydria. It is characterized by the presence of ...
Related Pictures
★リンクテーブル★
[★]
- 英
- mucolipidosis type IV、mucolipidosis IV
- 関
- I細胞病、ムコリピドーシス、シアリドーシス、ムコ脂質症IV型、ムコ脂質症I型、ムコリピドーシスI型、ムコ脂質症II型、ムコリピドーシスII型、ムコ脂質症III型、ムコリピドーシスIII型、偽性ハーラー・・リジストロフィー、さくらんぼ赤色斑ミオクローヌス症候群、ムコリピド症
[★]
ムコリピドーシスII型、ムコ脂質症II型
- 関
- cherry red spot myoclonus syndrome、I-cell disease、mucolipidosis、mucolipidosis I、mucolipidosis II、mucolipidosis III、mucolipidosis IV、mucolipidosis type I、mucolipidosis type III、mucolipidosis type IV、pseudo-Hurler polydystrophy、sialidosis
[★]
ムコリピドーシスI型、ムコ脂質症I型
- 関
- cherry red spot myoclonus syndrome、I-cell disease、mucolipidosis、mucolipidosis I、mucolipidosis II、mucolipidosis III、mucolipidosis IV、mucolipidosis type II、mucolipidosis type III、mucolipidosis type IV、pseudo-Hurler polydystrophy、sialidosis
[★]
- 英
- mucolipidosis type IV
- 関
- ムコリピドーシスIV型
[★]
- (windows)ファイル内容表示(linux -> cat])
- ex. type report_20111118.jp.htm | php a.php > report_20111118.jp.jp.jp.html
- 関
- form、mode、pattern、type specimen、typed
[★]
[★]
- 関
- i.v.、intravascular、intravenous、intravenously
[★]
- 関
- form、mode、pattern、type
[★]